Filter
621
Text search:
pharmaceutical
regulatory
authority
Featured
Recommendations
52
New Publications
197
Language
Document type
No document type
332
Studies & Reports
108
Guidelines
93
Manuals
36
Strategic & Response Plan
31
Fact sheets
8
Situation Updates
5
Training Material
4
Resource Platforms
2
Brochures
1
Infographics
1
Countries / Regions
Kenya
36
Ethiopia
30
India
25
Uganda
24
South Africa
20
Ghana
19
Tanzania
18
Liberia
16
Nigeria
16
Rwanda
16
Zambia
15
Malawi
13
Namibia
12
Nepal
11
Sierra Leone
10
Zimbabwe
10
Bangladesh
10
Western and Central Europe
10
Ukraine
8
Myanmar / Burma
8
Global
8
Lesotho
7
Eastern Europe
6
Philippines
5
Indonesia
5
Eswatini/ Swaziland
5
Botswana
5
Syria
4
Cambodia
4
Benin
3
Latin America and the Carribbean
3
Albania
3
Guinea
2
Senegal
2
Congo, Democratic Republic of
2
Cameroon
2
Haiti
2
Pakistan
2
Jordan
2
Thailand
2
West and Central Africa
2
Middle East and North Africa
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
Asia
2
Africa
2
Laos
2
USA
1
Somalia
1
Afghanistan
1
Germany
1
Chad
1
Mozambique
1
Papua New Guinea
1
Sudan
1
North Macedonia
1
East and Southern Africa
1
Western Pacific Region
1
Fiji
1
Timor Leste/ East Timor
1
Moldova
1
Australia
1
Vietnam
1
Gabon
1
Denmark
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
333
Clinical Guidelines
35
Pharmacy & Technologies
20
Key Resources
19
Women & Child Health
10
Public Health
8
Capacity Building
3
Toolboxes
Pharmacy
89
AMR
82
COVID-19
30
TB
23
HIV
20
Rapid Response
16
Mental Health
16
Global Health Education
9
NTDs
8
Ebola & Marburg
6
Conflict
6
Planetary Health
6
Health Financing Toolbox
6
Malaria
6
2.0 Rapid Response
6
NCDs
4
Specific Hazards
3
Caregiver
3
Polio
2
Refugee
2
Natural Hazards
1
Zika
1
PHARMA’S RESPONSE TO THE COVID-19 VACCINES CRISIS. Update Feb., 14, 2022. In September 2021, Amnesty International published A Double Dose of Inequality, which assessed the extent to which the pharmaceutical industry was restricting access to Covi
...
The guidelines reiterate that the general principles of ethics for biomedical research involving human participants shall also be applicable. In addition, the guidelines specify unique provisions for stem cells, because of their inherent property for unlimited proliferation, differentiation to cells
...
Comprehensive Reviews in Food Science and Food Safety, Vol.12 (2013) pp.234-248
In 2006, the Institute of Food Technologists (IFT) published an Expert Report entitled “Antimicrobial Resistance: Implications for the Food System” (IFT 2006). That report summarized current scientific knowledge pe
...
This third booklet of the World Drug Report 2022 has a dual focus: opioids and cannabis.
The first chapter of the booklet provides an overview of opioids as a group of substances and their patterns of non-medical use at the global level. It also reviews the latest trends in the global supply of opi
...
Drug Advisory Board
First edition, November 1997 | Revised July 2002
The growing challenges for people in low and middle-income countries to access new medicines.
Analysis 58
Access to controlled medicines. 3rd edition
Full eHandbook under: http://www.msh.org/resources/health-systems-in-action-an-ehandbook-for-leaders-and-managers
Effective supply management has the potential to make a powerful contribution to the reliable availability of essential medicines, which are a crucial part of the delivery of highqualit
...
Early-warning indicators to prevent stock-outs and overstocking of antiretroviral, antituberculosis and antimalaria medicines.
Lao People’s Democratic Republic (Lao PDR), also referred to as Laos, or Lao, is exposed to natural disasters such as flooding, typhoons, cyclones, drought, and earthquakes. The country is vulnerable to recurrent, sudden-onset and slow onset natural disasters with flooding, storms and typhoons hav
...
Prepared for the Stunting Prevention and Reduction Project - The project Medical Waste Management Plan’s (MWMP) overall objective is to prevent and/or mitigate the negative effects of increased generation of medical waste on human health and the environment. The plan proposes measures to prevent t
...
This field study to measure access to and use of medicines was undertaken in GHANA in May-June 2008. The study assessed information on the socio-economic level of households, and access to and use of medicines for acute and chronic conditions as well as opinions and perceptio
...
Annex 5, WHO Technical Report Series 1010, 2018
These guidelines for the National Pharmacovigilance and Medicine Information System in Rwanda have been developed to ensure that safe, efficacious and quality medicines are made available to all Rwandans.
Therapeutics Information and Pharmacovigilance Centre | TIPC
Situational Analysis: 13-23 October 2014
Report prepared using the WHO/SEARO workbook tool for undertaking a situational analysis of medicines in health care delivery in low and middle income countries
Report prepared using the WHO/SEARO workbook tool for undertaking a situational analysis of medicines in health care delivery in low and middle income countries
